Home | Cancers | Prostate Cancer

Prostate Cancer

Low-risk prostate cancer patients will benefit from active surveillance guidelines

New guidelines for active surveillance of prostate cancer will improve health outcomes for those with low grade diagnoses, according to two University ...

Prostate Cancer’s Penchant for Copper May Be a Fatal Flaw

By Duke Medicine News and Communications - DURHAM, N.C. – Like discriminating thieves, prostate cancer tumors scavenge and hoard copper that is ...

Elevated Cholesterol and Triglycerides May Increase the Risk for Prostate Cancer Recurrence

PHILADELPHIA — Higher levels of total cholesterol and triglycerides, two types of fat, in the blood of men who underwent surgery for prostate cancer, were associated with increased risk for disease recurrence, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. ... Full story

Researchers discover gene that can predict aggressive prostate cancer at diagnosis

Study identified a genetic variant near the KLK3 gene that could stratify GS7 prostate cancer patients ... Full story

European researchers meet to discuss prostate cancer diagnostic devices

European researchers met at the University of Bath to discuss clinical and commercial aspects of prostate cancer diagnostic devices. ... Full story

Men who are uneducated about their prostate cancer have difficulty making treatment choices

UCLA study finds that ‘decisional conflict’ could negatively impact quality of care and long-term outcomes ... Full story

Large Study Reveals New Genetic Variants that Raise Risk for Prostate Cancer

In an analysis of genetic information among more than 87,000 men, a global team of scientists says it has found 23 new genetic variants – common differences in the genetic code -- that increase a man’s risk for prostate cancer. The so-called “meta-analysis,” believed to be the largest of its kind, has revealed once hidden mutations among men in a broad array of ethnic groups comprising men of European, African, Japanese and Latino ancestry. ... Full story

Prostate cancer patients who receive hypofractionated radiation therapy report consistent quality of life before and after treatment

Prostate cancer patients who received hypofractionated (HPFX) radiation therapy (RT) reported that their quality of life, as well as bladder and bowel function were at similar levels before and after RT, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting. Additionally, results indicate that parallel quality of life outcomes occurred between groups of patients who receive different regimens of HPFX RT. ... Full story

Majority of prostate cancer patients surveyed five years after treatment with vessel-sparing radiation therapy report preserved sexual function

A comparison of five-year sexual function outcomes, as reported by patients treated with external beam radiotherapy (EBRT) versus combination EBRT plus brachytherapy, indicates that the utilization of vessel-sparing radiation therapy makes cure possible without compromising long-term sexual function, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting. ... Full story

Genetic Discovery Yields Prostate Cancer Test, Promise of Future Therapy

PITTSBURGH – A genetic discovery out of the University of Pittsburgh School of Medicine is leading to a highly accurate test for aggressive prostate cancer and identifies new avenues for treatment. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 144 | displaying: 1 - 10